Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT4 known ✓ | P35916 | 1/20 | 0.41 |
| ▸ | GRIN1 known ✓ | Q05586 | 2/20 | 0.36 |
| ▸ | GRIN2A known ✓ | Q12879 | 2/20 | 0.36 |
| ▸ | GRIN2B known ✓ | Q13224 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.44 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.41 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | HEXA | P06865 | 2/20 | 0.39 |
| ▸ | HEXB | P07686 | 2/20 | 0.39 |
| ▸ | OGA | O60502 | 1/20 | 0.39 |
| ▸ | TOP2A | P11388 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8130521 | 0.94 | HSP90AA1 (0.51) | HSP90AA1IDO1SIRT1TERTDYRK3 | |
| SCHEMBL7988885 | 0.85 | SIRT1 (0.44) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL8561951 | 0.80 | HSP90AA1 (0.43) | HSP90AA1IDO1TOP2A | |
| SCHEMBL8131634 | 0.79 | SIRT1 (0.49) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7982472 | 0.78 | SIRT1 (0.55) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7982431 | 0.78 | SIRT1 (0.41) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7984901 | 0.77 | SIRT1 (0.44) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7985094 | 0.76 | SIRT1 (0.44) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7985172 | 0.76 | SIRT1 (0.44) | SIRT1TERTDYRK3RPS6KB1EPHA2 | |
| SCHEMBL7982362 | 0.73 | HEXA (0.51) | SIRT1TERTDYRK3RPS6KB1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6300340-B1 | USEFUL FOR THERAPY OF CANCER AND SOLID TUMORS | ADIR ET COMPAGNIE (FR) | 2001-10-09 | — | — | US | disclosed |
| US-6162822-A | Bisimide compounds | ADIR ET COMPAGNIE (FR) | 2000-12-19 | — | — | US | disclosed |